Today: 9 April 2026
Browse Category

NASDAQ:BAVA 2 December 2025

Nasdaq Nordic Stock Market Today, 2 December 2025: OMXS30, OMXC25 and OMXH25 Edge Higher as Deals, Buybacks and IPOs Drive Action

Nasdaq Nordic Stock Market Today, 2 December 2025: OMXS30, OMXC25 and OMXH25 Edge Higher as Deals, Buybacks and IPOs Drive Action

Nordic stock benchmarks in Stockholm, Copenhagen, and Helsinki edged higher Tuesday, with OMXS30 up 0.2%, OMXC25 up 0.25%, and OMXH25 up 0.3%. Bavarian Nordic announced a DKK 500 million share buyback after a strong cash influx. Nordfyns Bank shares traded for the last time ahead of its merger with Middelfart Sparekasse. Global markets remained subdued after a weak start to December.
2 December 2025

Stock Market Today

  • Regeneron vs Illumina: Evaluating Value Stocks in Biomedical Sector
    April 9, 2026, 12:59 PM EDT. Investors eyeing the Medical - Biomedical and Genetics sector face a choice between Regeneron (REGN) and Illumina (ILMN). Regeneron holds a Zacks Rank of #2 (Buy) versus Illumina's #3 (Hold), signaling a more positive earnings revision trend. REGN's forward price-to-earnings (P/E) ratio is 17.49, notably lower than ILMN's 24.94, suggesting better valuation. The price-to-book (P/B) ratio of REGN stands at 2.62 compared to ILMN's 7.18, further indicating relative undervaluation. REGN's PEG ratio, which adjusts P/E for earnings growth, is 1.64 versus ILMN's 2.45. These metrics contribute to REGN earning a Value grade of B, surpassing ILMN's C. For value investors prioritizing fundamentals and positive earnings outlooks, REGN currently offers a stronger value proposition.

Latest article

Unilever Snaps Up Grüns to Deepen U.S. Wellness Push After McCormick Food Deal

Unilever Snaps Up Grüns to Deepen U.S. Wellness Push After McCormick Food Deal

9 April 2026
Unilever said Thursday it will acquire U.S. greens-supplement brand Grüns for an undisclosed sum, with the deal expected to close later this year pending approvals. Grüns was valued at about $500 million in a 2025 Series B round, according to Reuters. The purchase follows Unilever’s recent agreement to combine its food business with McCormick.
Lumentum Stock Nears $960 After JPMorgan, Mizuho Raise Targets on Nvidia AI Optics Demand

Lumentum Stock Nears $960 After JPMorgan, Mizuho Raise Targets on Nvidia AI Optics Demand

9 April 2026
Lumentum shares climbed Thursday after JPMorgan raised its price target to $950, following Mizuho’s hike to $930. The moves come after Nvidia agreed last month to invest $2 billion in Lumentum and make multibillion-dollar purchase commitments. Lumentum reported February quarter revenue of $665.5 million, up 65.5% year-over-year. An SEC filing showed Lumentum will swap 5.7 million shares for $474.6 million in convertible notes.
SBTi Says Corporate Climate Targets Jumped 40% in 2025 as Asia Closes In on Europe

SBTi Says Corporate Climate Targets Jumped 40% in 2025 as Asia Closes In on Europe

9 April 2026
The number of companies with Science Based Targets initiative-validated climate goals reached 9,764 by the end of 2025, up 40% from the previous year. Asia added 1,216 companies, nearly matching Europe’s increase. Europe held 49% of validated targets, Asia 36%, and North America 11%. Japan led single markets with 2,091 companies.
Palantir Stock Drops as Michael Burry Says Anthropic Is ‘Eating Its Lunch’

Palantir Stock Drops as Michael Burry Says Anthropic Is ‘Eating Its Lunch’

9 April 2026
Palantir Technologies dropped about 7% Thursday after Michael Burry said Anthropic was overtaking it in enterprise AI, putting Palantir on track to lose $34 billion in market value. Anthropic reported its annualized revenue run rate had surged past $30 billion and launched new AI tools for businesses. Nearly one in four businesses on Ramp now pays for Anthropic, according to Ramp data. Palantir’s stock still trades at 395 times earnings.
Salesforce Stock Hits Fresh 52-Week Low Despite AI Growth and $50 Billion Buyback

Salesforce Stock Hits Fresh 52-Week Low Despite AI Growth and $50 Billion Buyback

9 April 2026
Salesforce shares hit a new 52-week low Thursday, dropping 3.7% to $169.76 despite reporting 12% revenue growth and strong demand for its AI products. The broader software sector continued to slide, with the S&P 500 software and services index down about $1 trillion since January. Salesforce raised its buyback authorization to $50 billion and increased its dividend to 44 cents a share.
Go toTop